Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021

Heather Whitaker; Suzanne Elgohari; Cathy Rowe; Ashley Otter; Timothy Brooks; Ezra Linley; Iain Hayden; Sonia Ribeiro; Jacqueline Hewson; Anissa Lakhani; Eleanor Clarke; Camille Tsang; Colin Campbell; Mary Ramsay; Kevin Brown; Gayatri Amirthalingam

doi:10.1016/j.jinf.2021.04.037

Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021

Heather Whitaker^*, Suzanne Elgohari, Cathy Rowe, Ashley Otter, Timothy Brooks, Ezra Linley, Iain Hayden, Sonia Ribeiro, Jacqueline Hewson, Anissa Lakhani, Eleanor Clarke, Camille Tsang, Colin Campbell, Mary Ramsay, Kevin Brown, Gayatri Amirthalingam

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

13 Citations (Scopus)

Abstract

The COVID-19 vaccination programme commenced in England on 8th December 2020 primarily based on age; by 7th March 2021 approximately 93% of the English population aged 70+ years had received at least 1 dose of either the Pfizer BioNTech or AstraZeneca vaccines. Using a nucleoprotein assay that detects antibodies following natural infection only and a spike assay that detects infection and vaccine-induced responses, we aim to describe the impact of vaccination on SARS-CoV-2 antibody prevalence in English blood donors.

Original language	English
Pages (from-to)	269-271
Number of pages	3
Journal	Journal of Infection
Volume	83
Issue number	2
Early online date	11 May 2021
DOIs	https://doi.org/10.1016/j.jinf.2021.04.037
Publication status	Published - Aug 2021

Bibliographical note

Funding Information: Funding was provided through Public Health England.

EL reports the Public Health England Vaccine Evaluation Unit performs contract research on behalf of GSK, Sanofi and Pfizer which is outside the submitted work.

HW, SE, IH, SR, KB, GA, EC, AL, CT, CC, IH, SR, JH, CR, AO, TB, MR report no conflicts of interest.

Open Access: Free to read, but no Open Access licence

Publisher Copyright: Crown Copyright © 2021 Published by Elsevier Ltd on behalf of The British Infection Association. All rights reserved.

Citation: Heather J Whitaker, Suzanne Elgohari, Cathy Rowe, Ashley David Otter, Tim Brooks, Ezra Linley, Iain Hayden, Sonia Ribeiro, Jacqueline Hewson, Anissa Lakhani, Eleanor Clarke, Camille Tsang, Colin NJ Campbell, Mary Ramsay, Kevin Brown, Gayatri Amirthalingam, Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021, Journal of Infection, Volume 83, Issue 2, 2021, Pages 237-279, ISSN 0163-4453,

DOI: https://doi.org/10.1016/j.jinf.2021.04.037.

Keywords

Antibodies
Blood Donors
COVID-19
COVID-19 Serological Testing
COVID-19 vaccines
SARS-CoV-2
Surveys

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jinf.2021.04.037

Cite this

Whitaker, H., Elgohari, S., Rowe, C., Otter, A., Brooks, T., Linley, E., Hayden, I., Ribeiro, S., Hewson, J., Lakhani, A., Clarke, E., Tsang, C., Campbell, C., Ramsay, M., Brown, K., & Amirthalingam, G. (2021). Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021. Journal of Infection, 83(2), 269-271. https://doi.org/10.1016/j.jinf.2021.04.037

@article{d0d41423e25c4447815a389db2de7e95,

title = "Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021",

abstract = "The COVID-19 vaccination programme commenced in England on 8th December 2020 primarily based on age; by 7th March 2021 approximately 93% of the English population aged 70+ years had received at least 1 dose of either the Pfizer BioNTech or AstraZeneca vaccines. Using a nucleoprotein assay that detects antibodies following natural infection only and a spike assay that detects infection and vaccine-induced responses, we aim to describe the impact of vaccination on SARS-CoV-2 antibody prevalence in English blood donors.",

keywords = "Antibodies, Blood Donors, COVID-19, COVID-19 Serological Testing, COVID-19 vaccines, SARS-CoV-2, Surveys",

author = "Heather Whitaker and Suzanne Elgohari and Cathy Rowe and Ashley Otter and Timothy Brooks and Ezra Linley and Iain Hayden and Sonia Ribeiro and Jacqueline Hewson and Anissa Lakhani and Eleanor Clarke and Camille Tsang and Colin Campbell and Mary Ramsay and Kevin Brown and Gayatri Amirthalingam",

note = "Funding Information: Funding was provided through Public Health England. EL reports the Public Health England Vaccine Evaluation Unit performs contract research on behalf of GSK, Sanofi and Pfizer which is outside the submitted work. HW, SE, IH, SR, KB, GA, EC, AL, CT, CC, IH, SR, JH, CR, AO, TB, MR report no conflicts of interest. Open Access: Free to read, but no Open Access licence Publisher Copyright: Crown Copyright {\textcopyright} 2021 Published by Elsevier Ltd on behalf of The British Infection Association. All rights reserved. Citation: Heather J Whitaker, Suzanne Elgohari, Cathy Rowe, Ashley David Otter, Tim Brooks, Ezra Linley, Iain Hayden, Sonia Ribeiro, Jacqueline Hewson, Anissa Lakhani, Eleanor Clarke, Camille Tsang, Colin NJ Campbell, Mary Ramsay, Kevin Brown, Gayatri Amirthalingam, Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021, Journal of Infection, Volume 83, Issue 2, 2021, Pages 237-279, ISSN 0163-4453, DOI: https://doi.org/10.1016/j.jinf.2021.04.037.",

year = "2021",

month = aug,

doi = "10.1016/j.jinf.2021.04.037",

language = "English",

volume = "83",

pages = "269--271",

journal = "Journal of Infection",

issn = "0163-4453",

publisher = "British Infection Society",

number = "2",

}

Whitaker, H , Elgohari, S , Rowe, C , Otter, A , Brooks, T , Linley, E, Hayden, I, Ribeiro, S, Hewson, J, Lakhani, A, Clarke, E, Tsang, C, Campbell, C , Ramsay, M , Brown, K & Amirthalingam, G 2021, 'Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021', Journal of Infection, vol. 83, no. 2, pp. 269-271. https://doi.org/10.1016/j.jinf.2021.04.037

TY - JOUR

T1 - Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021

AU - Whitaker, Heather

AU - Elgohari, Suzanne

AU - Rowe, Cathy

AU - Otter, Ashley

AU - Brooks, Timothy

AU - Linley, Ezra

AU - Hayden, Iain

AU - Ribeiro, Sonia

AU - Hewson, Jacqueline

AU - Lakhani, Anissa

AU - Clarke, Eleanor

AU - Tsang, Camille

AU - Campbell, Colin

AU - Ramsay, Mary

AU - Brown, Kevin

AU - Amirthalingam, Gayatri

N1 - Funding Information: Funding was provided through Public Health England. EL reports the Public Health England Vaccine Evaluation Unit performs contract research on behalf of GSK, Sanofi and Pfizer which is outside the submitted work. HW, SE, IH, SR, KB, GA, EC, AL, CT, CC, IH, SR, JH, CR, AO, TB, MR report no conflicts of interest. Open Access: Free to read, but no Open Access licence Publisher Copyright: Crown Copyright © 2021 Published by Elsevier Ltd on behalf of The British Infection Association. All rights reserved. Citation: Heather J Whitaker, Suzanne Elgohari, Cathy Rowe, Ashley David Otter, Tim Brooks, Ezra Linley, Iain Hayden, Sonia Ribeiro, Jacqueline Hewson, Anissa Lakhani, Eleanor Clarke, Camille Tsang, Colin NJ Campbell, Mary Ramsay, Kevin Brown, Gayatri Amirthalingam, Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021, Journal of Infection, Volume 83, Issue 2, 2021, Pages 237-279, ISSN 0163-4453, DOI: https://doi.org/10.1016/j.jinf.2021.04.037.

PY - 2021/8

Y1 - 2021/8

N2 - The COVID-19 vaccination programme commenced in England on 8th December 2020 primarily based on age; by 7th March 2021 approximately 93% of the English population aged 70+ years had received at least 1 dose of either the Pfizer BioNTech or AstraZeneca vaccines. Using a nucleoprotein assay that detects antibodies following natural infection only and a spike assay that detects infection and vaccine-induced responses, we aim to describe the impact of vaccination on SARS-CoV-2 antibody prevalence in English blood donors.

AB - The COVID-19 vaccination programme commenced in England on 8th December 2020 primarily based on age; by 7th March 2021 approximately 93% of the English population aged 70+ years had received at least 1 dose of either the Pfizer BioNTech or AstraZeneca vaccines. Using a nucleoprotein assay that detects antibodies following natural infection only and a spike assay that detects infection and vaccine-induced responses, we aim to describe the impact of vaccination on SARS-CoV-2 antibody prevalence in English blood donors.

KW - Antibodies

KW - Blood Donors

KW - COVID-19

KW - COVID-19 Serological Testing

KW - COVID-19 vaccines

KW - SARS-CoV-2

KW - Surveys

UR - http://www.scopus.com/inward/record.url?scp=85111070431&partnerID=8YFLogxK

U2 - 10.1016/j.jinf.2021.04.037

DO - 10.1016/j.jinf.2021.04.037

M3 - Letter

C2 - 33989631

AN - SCOPUS:85111070431

SN - 0163-4453

VL - 83

SP - 269

EP - 271

JO - Journal of Infection

JF - Journal of Infection

IS - 2

ER -

Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this